medigraphic.com
SPANISH

Revista Médica de la Universidad Autónoma de Sinaloa REVMEDUAS

ISSN 2007-8013 (Print)
Órgano oficial de la Universidad Autónoma de Sinaloa
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2023, Number 4

<< Back Next >>

Rev Med UAS 2023; 13 (4)

Costs of polypharmacy in the elderly with type 2 diabetes mellitus

Guzmán-Priego CG, Quiroz-Gómez S, Celorio-Méndez KS, Baeza-Flores GC, Calles-Jiménez O, López-Jiménez NG
Full text How to cite this article

Language: English
References: 18
Page: 397-403
PDF size: 349.66 Kb.


Key words:

polypharmacy, aged, Diabetes Mellitus, Drug Costs, Health Care Costs.

ABSTRACT

Objective: Calculate the cost of polypharmacy in elderly patients with DM2.
Method: 104 clinical records of the basic nuclei of a General Hospital in Tabasco of elderly patients with DM2 were selected. The consumption of drugs and present pathologies were recorded; the cost of drugs and the demand for health services were estimated.
Results: It was found that 50% of the patients suffer from arterial hypertension in addition to DM2; 69.23% use 6 drugs; 28.85% of the patients came to 6 consultations; the annual per-ception of health services personnel was $3,652,140.2 MXN for doctors, $2,250,853 MXN for nursing, and $290,205.60 MXN for pharmacy personnel.
Conclusion: Promoting primary care is essential to reduce the incidence of chronic-degenerative diseases that, together with aging, lead to polypharmacy and a higher cost of care per patient.


REFERENCES

  1. Laidelbis MP, Arístides Ramón RJ, Nadia Inés IT. Caracterización del consumo de medicamentos en adultos mayores [Internet]. farmasalud2021.sld.cu. 2021 [cited 2023 Mar 6]. Available from: https://farmasalud2021.sld.cu/index.php/farmasalud/2021/paper/view/66

  2. Roca GIC, Ramos GK, Martínez GGJ, Pérez MD, González RMR. Characterization of polypharmacy in older adults consulted in an urban medical office. Mul Med. 2021;25(2). Available from: https://www.medigraphic.com/cgi-bin/new/resumenI.cgi?IDARTICULO=104893

  3. Cortes-García JC, Mejía-Rodríguez O. Polifarmacia en el adulto mayor:: Un coctel de fármacos con efectos de riesgo para la salud. Milenaria, Ciencia y Arte. 2022; (20):12-5. Available from: https://milenaria.umich.mx/ojs/index.php/milenaria/article/view/314

  4. León-Vázquez M, Seefoó-Jarquin P, Portillo-García Z, Ballinas-Irvin YR, Díaz-Álvarez G, Fonseca-Basurto D. Polifarmacia y cumplimiento terapéutico en el adulto mayor con diabetes mellitus tipo 2 e hipertensión arterial. Med Gen Fam. 2021;10(6):272–7. Available from: https://mgyf.org/polifarmacia-y-cumplimiento-terapeutico-en-el-adulto-mayor-con-diabetes-mellitus-tipo-2-e-hipertension-arterial/

  5. Sánchez-Pérez H, Ramírez-Rosillo FJ, Carrillo-Esper R. Polifarmacia en el adulto mayor. Consideraciones en el perioperatorio. Rev Mex Anestesiol. 2022;45(1):40–7. Available from: https://www.medigraphic.com/pdfs/rma/cma-2022/cma221i.pdf

  6. Arriagada L, Carrasco T, Araya M. Polifarmacia y deprescripción en personas mayores. Rev Med Clin Condes. 2020; 31(2):204–10. Available from: https://www.elsevier.es/es-revista-revista-medica-clinica-las-condes-202-articulo-polifarmacia-deprescripcion-personas-mayores-S0716864020300237

  7. Vega-López MG, González-Pérez GJ. Mortalidad por diabetes mellitus y su impacto en la esperanza de vida a los 60 años en México. Rev Saude Publica. 2021;55:61. Available from: https://www.scielo.br/j/rsp/a/ZcYRgq57DJS3XnSDghMfRLh/?format=pdf&lang=es

  8. Sistema de Información de la Secretaría de Salud [Internet]. Salud.gob.mx. 2018. [updated 2022; cited 2023 Apr 4]. Available from: http://sinaiscap.salud.gob.mx:8080/DGIS/

  9. Gomezcoello-Vásquez V, Caza M, Jácome-Sánchez E. Prevalencia de diabetes mellitus y sus complicaciones en adultos mayores en un centro de referencia. Rev Med Vozandes. 2020; 31(2):49–55. Available from: https://revistamedicavozandes.com/wp-content/uploads/2021/01/06_A0_06.pdf

  10. Díaz Rizzolo D, Caballero A. Envejecimiento y diabetes: una relación bidireccional [Internet]. Rev Diabetes. 2022 [cited 2023 Apr 5]. Available from: https://www.revistadiabetes.org/estilos-de-vida/envejecimiento-y-diabetes-una-relacion-bidireccional/

  11. Shamah-Levy T, Romero-Martínez M, Barrientos-Gutiérrez T, Cuevas-Nasu L, Bautista-Arredondo S, Colchero MA, et al. Encuesta Nacional de Salud y Nutrición 2021 sobre COVID-19. Resultados nacionales. Cuernavaca, México: Inst Nac Salud Public, 2022 [Internet]. 2022 [cited 2023 Apr 7]. Available from: https://www.insp.mx/resources/images/stories/2022/docs/220801_Ensa21_digital_29julio.pdf

  12. Informe Trimestral de Vigilancia Epidemiológica Hospitalaria Diabetes Mellitus Tipo 2 Corte al 03 de abril del 2023 Dirección de Vigilancia Epidemiológica de Enfermedades No Transmisibles. 2023 [cited 2023 Apr 20]. Available from: https://www.gob.mx/cms/uploads/attachment/file/822041/SVEHDMT2_1ETRIM_2023.pdf

  13. Ayala-Moreno M, Rendón ME, Arizmendi M del C, Castañeda A. Análisis del gasto social para la prevención y control de la diabetes; Perspectiva futura. RECEIN. 2020;14(54):49-0. Available from: https://revistasinvestigacion.lasalle.mx/index.php/recein/article/view/2464

  14. Sosa-Rubí SG, Contreras-Loya D, Pedraza-Arizmendi D, Chivardi-Moreno C, Alarid-Escudero F, López-Ridaura R, et al. Cost-effectiveness analysis of a multidisciplinary health-care model for patients with type-2 diabetes implemented in the public sector in Mexico: A quasi-experimental, retrospective evaluation. Diabetes Res Clin Pract. 2020;167:108336. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010712/

  15. Pérez-Lozano DL, Camarillo-Nava VM, Juárez-Zepeda TE, Andrade-Pineda JE, Lucho-Gutiérrez ZM, Reyes-Pacheco JA et al. Costo-efectividad del tratamiento de la diabetes mellitus tipo 2 en México. Rev Med Inst Mex Seguro Soc. 2023;61(2):172-80. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10396055/

  16. Picó-Guzmán FJ, Martínez-Montañez OG, Ruelas-Barajas E, Hernández-Ávila M. Estimación del impacto económico por complicaciones cardiovasculares y de diabetes mellitus 2019-2028. Rev Med Inst Mex Seguro Soc. 2022 [cited july 11 2023]. Available from: http://revistamedica.imss.gob.mx/editorial/index.php/revista_medica/article/view/4962

  17. Gagliardino JJ, Olivera EM, Etchegoyen GS, Gonzalez C, Guidi ML. Evaluación y costos del proceso de atención de pacientes diabéticos [Internet]. Medicinabuenosaires.com. 2000 [cited july 12 2023]. Available from: http://www.medicinabuenosaires.com/revistas/vol60-00/6/v60_n6_p880_888.pdf

  18. DOF - Diario Oficial de la Federación [Internet]. Gob.mx. [cited july 26 2023]. Available from: https://dof.gob.mx/nota_detalle_popup.php?codigo=5272787




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Med UAS. 2023;13